UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Rho-kinase inhibitor coupled to peptide-modified albumin carrier reduces portal pressure and increases renal perfusion in cirrhotic rats

Scientific reports, 2019-02, Vol.9 (1), p.2256-2256, Article 2256

2019

Link zum Volltext

Verfügbarkeit prüfen

Hepatic inflammasome activation as origin of Interleukin-1α and Interleukin-1β in liver cirrhosis

Gut, 2021-09, Vol.70 (9), p.1799

2021

Link zum Volltext

Verfügbarkeit prüfen

Circulating microbiome in blood of different circulatory compartments

Gut, 2019-03, Vol.68 (3), p.578

2019

Link zum Volltext

Verfügbarkeit prüfen

Role of portal venous platelet activation in patients with decompensated cirrhosis and TIPS

Gut, 2020-08, Vol.69 (8), p.1535

2020

Link zum Volltext

Verfügbarkeit prüfen

Two-dimensional shear wave elastography predicts survival in advanced chronic liver disease

Gut, 2022-02, Vol.71 (2), p.402

2022

Link zum Volltext

Verfügbarkeit prüfen

Sympathetic nervous activation, mitochondrial dysfunction and outcome in acutely decompensated cirrhosis: the metabolomic prognostic models (CLIF-C MET)

Gut, 2023-08, Vol.72 (8), p.1581

2023

Link zum Volltext

Verfügbarkeit prüfen

Janus-kinase-2 relates directly to portal hypertension and to complications in rodent and human cirrhosis

Gut, 2017-01, Vol.66 (1), p.145

2017

Link zum Volltext

Verfügbarkeit prüfen

The soluble guanylate cyclase stimulator riociguat reduces fibrogenesis and portal pressure in cirrhotic rats

Scientific reports, 2018-06, Vol.8 (1), p.9372-13, Article 9372

2018

Link zum Volltext

Verfügbarkeit prüfen

Variation in Bile Microbiome by the Etiology of Cholestatic Liver Disease

Liver transplantation, 2020-12, Vol.26 (12), p.1652-1657

2020

Link zum Volltext

Verfügbarkeit prüfen

The Role of Hypoxia-Inducible Factor 1 Alpha in Acute-on-Chronic Liver Failure

International journal of molecular sciences, 2024-02, Vol.25 (3), p.1542

2024

Link zum Volltext

Verfügbarkeit prüfen

TGR(mREN2)27 rats develop non-alcoholic fatty liver disease-associated portal hypertension responsive to modulations of Janus-kinase 2 and Mas receptor

Scientific reports, 2019-08, Vol.9 (1), p.11598-10, Article 11598

2019

Link zum Volltext

Verfügbarkeit prüfen

Recent Advances in Practical Methods for Liver Cell Biology: A Short Overview

International journal of molecular sciences, 2020-03, Vol.21 (6), p.2027

2020

Link zum Volltext

Verfügbarkeit prüfen

Short-Term Western Diet Aggravates Non-Alcoholic Fatty Liver Disease (NAFLD) With Portal Hypertension in TGR(mREN2)27 Rats

International journal of molecular sciences, 2020-05, Vol.21 (9), p.3308

2020

Link zum Volltext

Verfügbarkeit prüfen

Pathophysiological role of prostanoids in coagulation of the portal venous system in liver cirrhosis

PloS one, 2019-10, Vol.14 (10), p.e0222840-e0222840

2019

Link zum Volltext

Verfügbarkeit prüfen

Novel Rat Model of Repetitive Portal Venous Embolization Mimicking Human Non-Cirrhotic Idiopathic Portal Hypertension

PloS one, 2016-09, Vol.11 (9), p.e0162144-e0162144

2016

Link zum Volltext

Verfügbarkeit prüfen

Baseline Presence of NAFLD Predicts Weight Loss after Gastric Bypass Surgery for Morbid Obesity

Journal of clinical medicine, 2020-10, Vol.9 (11), p.3430

2020

Link zum Volltext

Verfügbarkeit prüfen

Myostatin is associated with the presence and development of acute-on-chronic liver failure

JHEP reports, 2023-08, Vol.5 (8), p.100761-100761, Article 100761

2023

Link zum Volltext

Verfügbarkeit prüfen

Effects of Ethanol Feeding in Early-Stage NAFLD Mice Induced by Western Diet

Livers, 2021-03, Vol.1 (1), p.27-39

2021

Link zum Volltext

Verfügbarkeit prüfen

Liver transplantation for patients with acute-on-chronic liver failure (ACLF) in Europe: Results of the ELITA/EF-CLIF collaborative study (ECLIS)

Journal of hepatology, 2021-09, Vol.75 (3), p.610-622

2021

Link zum Volltext

Verfügbarkeit prüfen

Rationale for the use of statins in liver disease

American journal of physiology: Gastrointestinal and liver physiology, 2017-05, Vol.312 (5), p.G407-G412

2017

Link zum Volltext

Verfügbarkeit prüfen

The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology

Journal of hepatology, 2020-10, Vol.73 (4), p.842-854

2020

Link zum Volltext

Verfügbarkeit prüfen

PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis

Journal of hepatology, 2021-05, Vol.74 (5), p.1097-1108

2021

Link zum Volltext

Verfügbarkeit prüfen

Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS

Journal of hepatology, 2020-11, Vol.73 (5), p.1082-1091

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 57

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(47)

Publikationsform

Artikel
(56)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Rho-kinase inhibitor coupled to peptide-modified albumin carrier reduces portal pressure and increases renal perfusion in cirrhotic rats

Hepatic inflammasome activation as origin of Interleukin-1α and Interleukin-1β in liver cirrhosis

Circulating microbiome in blood of different circulatory compartments

Differential inflammasome activation predisposes to acute-on-chronic liver failure in human and experimental cirrhosis with and without previous decompensation

Role of portal venous platelet activation in patients with decompensated cirrhosis and TIPS

Two-dimensional shear wave elastography predicts survival in advanced chronic liver disease

Sympathetic nervous activation, mitochondrial dysfunction and outcome in acutely decompensated cirrhosis: the metabolomic prognostic models (CLIF-C MET)

Janus-kinase-2 relates directly to portal hypertension and to complications in rodent and human cirrhosis

The soluble guanylate cyclase stimulator riociguat reduces fibrogenesis and portal pressure in cirrhotic rats

Variation in Bile Microbiome by the Etiology of Cholestatic Liver Disease

Terlipressin therapy is associated with increased risk of colonisation with multidrug‐resistant bacteria in patients with decompensated cirrhosis

The Role of Hypoxia-Inducible Factor 1 Alpha in Acute-on-Chronic Liver Failure

TGR(mREN2)27 rats develop non-alcoholic fatty liver disease-associated portal hypertension responsive to modulations of Janus-kinase 2 and Mas receptor

Recent Advances in Practical Methods for Liver Cell Biology: A Short Overview

Short-Term Western Diet Aggravates Non-Alcoholic Fatty Liver Disease (NAFLD) With Portal Hypertension in TGR(mREN2)27 Rats

Pathophysiological role of prostanoids in coagulation of the portal venous system in liver cirrhosis

Novel Rat Model of Repetitive Portal Venous Embolization Mimicking Human Non-Cirrhotic Idiopathic Portal Hypertension

Baseline Presence of NAFLD Predicts Weight Loss after Gastric Bypass Surgery for Morbid Obesity

Myostatin is associated with the presence and development of acute-on-chronic liver failure

Effects of Ethanol Feeding in Early-Stage NAFLD Mice Induced by Western Diet

Liver transplantation for patients with acute-on-chronic liver failure (ACLF) in Europe: Results of the ELITA/EF-CLIF collaborative study (ECLIS)

Rationale for the use of statins in liver disease

The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology

PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis

Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS

Suchergebnisse filtern